NCT00205231View on ClinicalTrials.gov

A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease

NACompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

May 1, 2004

Study Completion Date

May 1, 2004

Conditions

HIV Infections

Interventions

DRUG

etanercept

Trial Locations (1)

53792

University of Wisconsin Hospital and Clinics, Madison

Sponsors

Collaborators (1)

Immunex Corporation

All Listed Sponsors

collaborator

Immunex Corporation

INDUSTRY

lead

University of Wisconsin, Madison

OTHER